Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir

The Journal of Clinical Investigation
Romain CoriatFrédéric Batteux

Abstract

The majority of patients receiving the platinum-based chemotherapy drug oxaliplatin develop peripheral neurotoxicity. Because this neurotoxicity involves ROS production, we investigated the efficacy of mangafodipir, a molecule that has antioxidant properties and is approved for use as an MRI contrast enhancer. The effects of mangafodipir were examined in mice following treatment with oxaliplatin. Neurotoxicity, axon myelination, and advanced oxidized protein products (AOPPs) were monitored. In addition, we enrolled 23 cancer patients with grade ≥ 2 oxaliplatin-induced neuropathy in a phase II study, with 22 patients receiving i.v. mangafodipir following oxaliplatin. Neuropathic effects were monitored for up to 8 cycles of oxaliplatin and mangafodipir. Mangafodipir prevented motor and sensory dysfunction and demyelinating lesion formation. In mice, serum AOPPs decreased after 4 weeks of mangafodipir treatment. In 77% of patients treated with oxaliplatin and mangafodipir, neuropathy improved or stabilized after 4 cycles. After 8 cycles, neurotoxicity was downgraded to grade ≥ 2 in 6 of 7 patients. Prior to enrollment, patients received an average of 880 ± 239 mg/m2 oxaliplatin. Patients treated with mangafodipir tolerated an addi...Continue Reading

References

Jan 11, 1990·The New England Journal of Medicine·J E Mollman
Jul 1, 1984·Neurology·R I RoelofsL Rosenberg
Jan 1, 1994·Methods in Enzymology·M L Hu
Sep 15, 1994·Biochemical and Biophysical Research Communications·H MasudaU Takahama
May 1, 1996·Kidney International·V Witko-SarsatB Descamps-Latscha
Feb 27, 1999·Toxicological Sciences : an Official Journal of the Society of Toxicology·J HolmesS G Chaney
Feb 5, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F Maindrault-GoebelA de Gramont
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A de GramontA Bonetti
Sep 30, 2000·European Journal of Pharmacology·H AdelsbergerC Lersch
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H WilsonJean L Grem
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefano CascinuGiuseppina Catalano
Jun 5, 2003·Expert Opinion on Pharmacotherapy·Jörg Thomas Hartmann, Hans-Peter Lipp
Oct 22, 2003·Journal of Hepatology·Sassia BeddaFrédéric Batteux
Jun 4, 2004·The New England Journal of Medicine·Thierry AndréUNKNOWN Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
Feb 16, 2006·Journal of the National Cancer Institute·Jérôme AlexandreFrédéric Batteux
Oct 24, 2006·Toxicology in Vitro : an International Journal Published in Association with BIBRA·F RovettaG Mazzoleni
Sep 21, 2007·Journal of Neuropathology and Experimental Neurology·Daniel P Perl, C Warren Olanow
Nov 6, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Matthew C Kiernan
Feb 19, 2008·Cancer Treatment Reviews·Andreas A ArgyriouHaralabos P Kalofonos
Mar 19, 2008·Journal of the Peripheral Nervous System : JPNS·Arun V KrishnanMatthew C Kiernan
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Cynthia D AngArtemio A Roxas
Jan 14, 2009·Journal of Negative Results in Biomedicine·Amir BroomandFredrik Elinder
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susanna B ParkMatthew C Kiernan
Feb 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Loïs S MiraucourtDaniel L Voisin
Apr 2, 2009·Journal of the Peripheral Nervous System : JPNS·Delphine BoërioHugh Bostock
Jul 25, 2009·The Journal of Pharmacology and Experimental Therapeutics·Tsung-Tair Yang, Su-Jane Wang
Dec 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GrotheyCharles L Loprinzi
Mar 26, 2011·EMBO Molecular Medicine·Juliette DescoeurEmmanuel Bourinet
Aug 26, 2011·Neurology·A Z BurakgaziMichael Polydefkis
Nov 11, 2011·PloS One·Romain CoriatFrédéric Batteux
Feb 16, 2012·Muscle & Nerve·Alexander G Dimitrov, Nonna A Dimitrova
Jun 23, 2012·Anti-cancer Agents in Medicinal Chemistry·Alexia KagiavaGeorge Theophilidis

❮ Previous
Next ❯

Citations

Nov 5, 2014·Nature Reviews. Neurology·Marco SisignanoGerd Geisslinger
Sep 17, 2014·Expert Opinion on Investigational Drugs·Douglas W SborovPamela J Harris
Oct 27, 2016·BMC Complementary and Alternative Medicine·Eun-Sang ChoNo Soo Kim
Dec 21, 2013·The Journal of Clinical Investigation·Deirdre R PachmanLauren E Ta
Jan 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carole Nicco, Frédéric Batteux
Mar 28, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yannick NeyClaus Jacob
Nov 14, 2017·Chemistry : a European Journal·Rosalin Bonetta
Dec 16, 2017·Acta Oncologica·Jan Olof G Karlsson, Per Jynge
Feb 3, 2018·Acta Oncologica·Bengt GlimeliusJacques Näsström
Jan 19, 2019·Acta Neuropathologica Communications·Olivier CerlesFrédéric Batteux
Aug 29, 2019·International Journal of Cancer. Journal International Du Cancer·Indiara BruscoGabriela Trevisan
Oct 29, 2018·Reproductive Biology and Endocrinology : RB&E·Ying QinFumitaka Kikkawa
Feb 28, 2020·Journal of Molecular Neuroscience : MN·Marie-Louise MalletPanagiotis Zis
Aug 31, 2017·Aging·Ryan CloydJose F Abisambra
Jun 27, 2017·Clinical and Experimental Pharmacology & Physiology·Larissa F CarvalhoAdriana A Carvalho
Aug 7, 2015·Toxics·Alessia ChiorazziPaola Marmiroli
Oct 1, 2020·Contrast Media & Molecular Imaging·Per JyngeJan O G Karlsson
Dec 30, 2014·Médecine sciences : M/S·Frédéric BatteuxCarole Nicco
Jun 27, 2018·Journal of Experimental & Clinical Cancer Research : CR·Rodrigo Prieto-BermejoÁngel Hernández-Hernández
May 14, 2020·Mini Reviews in Medicinal Chemistry·Mohsen DoostmohammadiSeeram Ramakrishna
Dec 17, 2016·Molecular Cancer Therapeutics·Olivier CerlesCarole Nicco
Jan 20, 2021·Journal of the Peripheral Nervous System : JPNS·Guoli WeiJiege Huo
Oct 24, 2020·International Journal of Molecular Sciences·Jelena S Katanic StankovicGvozden Rosic
Jun 29, 2021·Neuroscience Letters·Timothy M Doyle, Daniela Salvemini

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test

Clinical Trials Mentioned

NCT00727922

Software Mentioned

Qtrac
SAS

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.